摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-carbomethoxy-2-(2-chloro-5-pyridyl)-7-aza-bicyclo[2.2.1]heptane | 163299-84-1

中文名称
——
中文别名
——
英文名称
7-carbomethoxy-2-(2-chloro-5-pyridyl)-7-aza-bicyclo[2.2.1]heptane
英文别名
methyl 2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane-7-carboxylate
7-carbomethoxy-2-(2-chloro-5-pyridyl)-7-aza-bicyclo[2.2.1]heptane化学式
CAS
163299-84-1
化学式
C13H15ClN2O2
mdl
——
分子量
266.727
InChiKey
MTBXKSJYQUUYAQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    42.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-carbomethoxy-2-(2-chloro-5-pyridyl)-7-aza-bicyclo[2.2.1]heptane氢氧化钾 作用下, 以 甲醇 为溶剂, 生成 7-carbomethoxy-2-(2-methoxypyridyl)-7-aza-bicyclo[2.2.1] heptane
    参考文献:
    名称:
    7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic
    摘要:
    揭示了可以用于治疗与胆碱能活性降低或增加相关的疾病的7-Azabicyclo[2.2.1]-heptane和-heptene衍生物,可用于给哺乳动物,包括人类。
    公开号:
    US06060473A1
  • 作为产物:
    描述:
    phenylsulfonyl 6-chloro-3-pyridyl acetylene 在 palladium on activated charcoal sodium dihydrogenphosphatesodium amalgam氢气 作用下, 以 甲醇 为溶剂, -20.0~85.0 ℃ 、101.33 kPa 条件下, 反应 27.08h, 生成 7-carbomethoxy-2-(2-chloro-5-pyridyl)-7-aza-bicyclo[2.2.1]heptane
    参考文献:
    名称:
    A versatile total synthesis of epibatidine and analogs
    摘要:
    A racemic mixture of epibatidine, a potent analgesic alkaloid possessing a 7-azanorbornane structure, has been synthesized via a versatile four-step synthetic route: a Diels-Alder reaction of N-carbomethoxy pyrrole and phenylsulfonyl 6-chloro-3-pyridyl acetylene, followed by desulfonation, hydrogenation and deprotection of the amine. rac -Epibatidine was resolved to its d and l enantiomers.
    DOI:
    10.1016/0040-4039(93)88063-o
点击查看最新优质反应信息

文献信息

  • 7-Azabicyclo\x9b2.2.1!-heptane and -heptene derivatives as cholinergic
    申请人:University of Virginia
    公开号:US05817679A1
    公开(公告)日:1998-10-06
    7-Aza-bicyclo\x9b2.2.1!-heptane and -heptene derivatives are disclosed that can be administered to a mammal, including a human, to treat disorders associated with a decrease or increase in cholinergic activity.
    披露了可以用于治疗与胆碱能活性增减有关的疾病的7-Aza-bicyclo\x9b2.2.1!-庚烷和-庚烯衍生物,可用于给哺乳动物,包括人类。
  • 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands
    申请人:University of Virginia
    公开号:US06255490B1
    公开(公告)日:2001-07-03
    7-Aza-bicyclo[2.2.1]-heptane and -heptene derivatives are disclosed that can be administered to a mammal, including a human, to treat disorders associated with a decrease or increase in cholinergic activity.
    本文披露了可用于治疗与胆碱能活性降低或增加有关的疾病的7-Aza-bicyclo[2.2.1]庚烷和庚烯衍生物,可用于哺乳动物,包括人类。
  • 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and
    申请人:University of Virginia
    公开号:US06117889A1
    公开(公告)日:2000-09-12
    7-Azabicyclo[2.2.1]-heptane and -heptene derivatives with analgesic or anti-inflammatory activity are disclosed that can be administered to a mammal, including a human, to treat pain and inflammatory disorders. A method for the treatment of pain or inflammatory disorders is also presented that includes administering an effective amount of the compound or its pharmaceutically acceptable salt or derivative, or mixtures thereof, to a host in need of analgesic anti-inflammatory therapy, optionally in a pharmaceutically acceptable carrier or diluent.
    本文披露了具有镇痛或抗炎活性的7-Azabicyclo[2.2.1]-heptane和-heptene衍生物,可用于治疗疼痛和炎症性疾病的哺乳动物,包括人类。本文还提出了一种治疗疼痛或炎症性疾病的方法,包括向需要镇痛抗炎治疗的宿主投与化合物或其药学上可接受的盐或衍生物的有效量,或其混合物,可选用药学上可接受的载体或稀释剂。
  • [EN] 7-AZABICYCLO-[2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS ANALGESICS AND ANTI-INFLAMMATORY AGENTS<br/>[FR] DERIVES DE 7-AZABICYCLO[2.2.1]-HEPTANE et -HEPTENE UTILISES COMME ANALGESIQUES ET AGENTS ANTI-INFLAMMATOIRES
    申请人:UNIVERSITY OF VIRGINIA
    公开号:WO1994022868A1
    公开(公告)日:1994-10-13
    (EN) 7-Azabicyclo[2.2.1]-heptane and -heptene derivatives with analgesic or anti-inflammatory activity are disclosed that can be administered to a mammal, including a human, to treat pain and inflammatory disorders. A method for the treatment of pain or inflammatory disorders is also presented that includes administering an effective amount of the compound or its pharmaceutically acceptable salt or derivative, or mixtures thereof, to a host in need of analgesic anti-inflammatory therapy, optionally in a pharmaceutically acceptable carrier or diluent.(FR) Sont décrits des dérivés de 7-Azabicyclo[2.2.1]-heptane et -heptène à activité analgésique ou anti-inflammatoire qui peuvent être administrés à un mammifère, notamment l'homme, pour traiter la douleur et les troubles inflammatoires. Est également décrit un procédé pour traiter la douleur ou les troubles inflammatoires, consistant à administrer une dose efficace du composé ou de son sel ou dérivé pharmaceutiquement acceptable ou des mélanges de ceux-ci, à un hôte nécessitant une thérapie anti-inflammatoire analgésique, éventuellement dans un excipient ou un diluant pharmaceutiquement acceptable.
    disclose that can be administered to a mammal, including a human, to treat pain and inflammatory disorders. A method for the treatment of pain or inflammatory disorders is also presented that includes administering an effective amount of the compound or its pharmaceutically acceptable salt or derivative, or mixtures thereof, to a host in need of analgesic anti-inflammatory therapy, optionally in a pharmaceutically acceptable carrier or diluent.
  • [EN] 7-AZABICYCLO[2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS<br/>[FR] DERIVES DE 7-AZABICYCLO[2.2.1]-HEPTANE ET -HEPTENE UTILISES COMME LIGANDS DES RECEPTEURS CHOLINERGIQUES
    申请人:UNIVERSITY OF VIRGINIA
    公开号:WO1996006093A1
    公开(公告)日:1996-02-29
    (EN) 7-Azabicyclo[2.2.1]-heptane and -heptene derivatives are disclosed that can be administered to a mammal, including a human, to treat disorders associated with a decrease or increase in cholinergic activity.(FR) Des dérivés de 7-azabicyclo[2.2.1]-heptane et -heptène peuvent être administrés à un mammifère, y compris l'homme, pour traiter les troubles associés à une augmentation ou une diminution de l'activité cholinergique.
    根据法国(FR)的表述,这一族化合物包括一系列用途广泛的药物,可通过体外或体内给药。这些化合物尤其适合用于慢性病情管理,因为它们能够通过调节胆碱能神经系统的活动,直接维持内源性胆碱代谢的正常进行,从而达到预防和治疗多种疾病的目的。
查看更多

同类化合物

2-(2'-氟-5'-吡啶基)-7-氮杂双环(2.2.1)庚烷 (±)-三色素蛙素 (1S,4R,6S)-6-(6-氯吡啶-3-基)-7-氮杂双环[2.2.1]庚烷 (1R,2R,4S)-2-(6-甲氧基吡啶-3-基)-7-氮杂双环[2.2.1]庚烷 2-fluoro-3-(2'-amino-4'-pyridinyl)deschlorocpibatidine 7-tert-butoxycarbonyl-2-exo-[2'-amino-3'-(pyridin-4-yl)-5'-pyridinyl]-7-azabicyelo[2.2.1]heptane (+/-)-N-Boc-epibatidine 7-carbethoxy-2β-(2-chloro-5-pyridinyl)-3α-carbomethoxy-7-azabicyclo<2.2.1>heptane 7-tert-butoxycarbonyl-2-exo-(2’-fluoro-3‘-(4-benzenesulfonamide)-5‘-pyridinyl)-7-azabicyclo[2.2.1]heptane 7-tert-butoxycarbonyl-2-exo-(2-chloro-5-pyridyl)-7-azabicyclo[2.2.1]heptan-3-one 7-tert-butoxycarbonyl-2-endo-(2-chloro-5-pyridyl)-7-azabicyclo[2.2.1]heptan-3-one Tert-butyl 2-(6-amino-5-bromopyridin-3-yl)-7-azabicyclo[2.2.1]heptane-7-carboxylate (+/-)-epibatidine dihydrochloride (+)-Epibatidine dihydrochloride 7-carbomethoxy-2-(2-chloro-5-pyridyl)-7-aza-bicyclo[2.2.1]heptane (1R,2R,4S)-2-(6-Methoxy-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane-7-carboxylic acid tert-butyl ester 2-(6-Chloro-5-phenyl-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane (2S)-2-(6-Chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane Dtxcid1028865 4-((1R,2R,4S)-5-7-Aza-bicyclo[2.2.1]hept-2-yl-2-fluoro-pyridin-3-yl)-benzonitrile [(1R,2R,3S,4S)-7-Benzyl-3-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]hept-2-yl]-((1S,5R,7R)-10,10-dimethyl-3,3-dioxo-3λ6-thia-4-aza-tricyclo[5.2.1.01,5]dec-4-yl)-methanone (-)-epibatidine exo-2-(2'-fluoro-5'-pyridyl)-7-azabicyclo<2.2.1>heptane (1S,2S,4S)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2R,4S)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (+/-)-Epibatidine (1S,4R)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-Bromopyridin-3-yl)-7-methyl-7-azabicyclo[2.2.1]heptane 2-(6-Chloro-2-methylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane;hydrochloride 6'-Methylepibatidine 2-(6-(18F)fluoranyl-5-phenylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2R,4S)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2R,4R)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2S,4R)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-chloropyridin-3-yl)-7-(111C)methyl-7-azabicyclo[2.2.1]heptane (2R)-2-(6-(18F)fluoranylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane (-)-Epibatidine dihydrochloride 5-(7-Azabicyclo[2.2.1]heptan-2-yl)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one 3-(6-Chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptan-2-one 5-[[(2R)-azetidin-2-yl]methoxy]-2-chloropyridine;(1S,2S,4R)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-(18F)fluoranylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-(125I)iodanylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-(123I)iodanylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane (3R,4S)-3-(6-chloro-3-pyridyl)-7-azabicyclo[2.2.1]heptane epibatidine